Press Releases - 2020-02-10

Date	Title	Company
10-Feb-2020	Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2020 Ended December 31, 2019 and Provides Conference Call Information	Elite Pharmaceuticals, Inc.
10-Feb-2020	Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV(TM) (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer	Astellas
10-Feb-2020	Janssen Announces Submission to U.S. FDA for New DARZALEX® (Daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple Myeloma	Janssen Oncology
10-Feb-2020	Protalix BioTherapeutics Presents Key Clinical Data of Pegunigalsidase Alfa for the Treatment of Fabry Disease at the 16th Annual WORLDSymposium(TM) 2020	Protalix BioTherapeutics, Inc.
10-Feb-2020	Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results	Luminex Corporation
10-Feb-2020	Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares	Theravance Biopharma, Inc.
10-Feb-2020	Halozyme To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call	Halozyme Therapeutics, Inc.
10-Feb-2020	Scottish Medicines Consortium (SMC) says ‘yes’ to targeted combination therapy for both treatment-naïve and previously treated adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation	OPEN Health
10-Feb-2020	Sirtex Medical Announces Closing of Strategic Transaction with OncoSec Medical, Inc.	Sirtex
10-Feb-2020	Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020	Clarivate Analytics
10-Feb-2020	Vectura announces the appointment of Sharon Johnson, Executive Vice President for Delivery Management New organisational structure to drive innovation, customer focus and growth	Vectura Group plc
10-Feb-2020	Nanoform establishes US subsidiary	Nanoform
10-Feb-2020	Development of Novodiag® assay for safe and easy molecular testing of novel coronavirus and influenza viruses	Automobi Molecular Diagnostic Co., Ltd
10-Feb-2020	HumanOptics AG: Correction of the expected earnings forecast for the current financial year 2019/2020	HumanOptics AG
10-Feb-2020	CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors	CollPlant
10-Feb-2020	Compugen to Release Fourth Quarter and Full Year 2019 Results on Thursday, February 20, 2020	Compugen Ltd.
10-Feb-2020	CPhI Southeast Asia Report: executives call for track-and-trace schemes in Southeast Asia	CPhI
10-Feb-2020	HPAPI 2020 conference to discuss containment solutions and ADC developments	SMi Group Ltd
10-Feb-2020	CO.DON AG adds contract manufacturing to its product portfolio	CO.DON AG
10-Feb-2020	4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares (news with additional features)	4basebio AG